As per MRFR analysis, the US Surgical Chips Market Size was estimated at 1.43 (USD Billion) in 2023. The US Surgical Chips Market Industry is expected to grow from 1.55(USD Billion) in 2024 to 3.5 (USD Billion) by 2035. The US Surgical Chips Market CAGR (growth rate) is expected to be around 7.686% during the forecast period (2025 - 2035).
The US Surgical Chips Market is currently witnessing several important trends that are shaping its development. One key market driver is the increased demand for minimally invasive surgical techniques, which enhance patient recovery times and reduce the overall risk of complications. This demand is fueled by a growing awareness among patients about the benefits of less invasive options.
Furthermore, advancements in technology, particularly in imaging and sensor devices, are expanding the capabilities of surgical chips. As a result, surgeons in the US are increasingly relying on these chips for improved accuracy and precision during procedures. Opportunities in the market are emerging from the integration of artificial intelligence and machine learning into surgical procedures.
These technologies can analyze massive amounts of data and provide critical insights, enhancing decision-making during surgeries. The ongoing research and development initiatives funded by government institutions, like the National Institutes of Health, are promoting innovation within this space, making it ripe for investment and new product launches.
In recent times, there has been a noticeable trend towards regulatory approvals for new surgical devices, which is encouraging manufacturers to invest in the development of cutting-edge surgical technologies. This regulatory environment is progressively streamlining the pathway for new surgical chips to enter the market. Additionally, partnerships and collaborations between technology companies and healthcare providers are increasing, as stakeholders seek to share knowledge and improve surgical outcomes.
Collectively, these trends highlight a rapidly evolving landscape in the US Surgical Chips Market, where technological advancements and regulatory support are driving significant growth opportunities.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The US Surgical Chips Market Industry is experiencing substantial growth due to the increasing number of surgical procedures being performed each year. According to the American College of Surgeons, there were over 15 million inpatient surgical procedures performed in the United States in 2019, a number that has been consistently rising. This trend is expected to continue as advancements in technology and minimally invasive procedures gain popularity, leading to a higher demand for surgical chips used in various operations.
The Centers for Medicare & Medicaid Services (CMS) have also projected an increase in surgical volumes, attributing this growth to factors such as an aging population, the rise in chronic diseases, and improvements in surgical techniques. As a result, the demand for surgical chips, which facilitate various aspects of surgical operations, is on the rise, further propelling the growth of the US Surgical Chips Market Industry.
The US Surgical Chips Market Industry is significantly influenced by technological advancements and innovation in surgical equipment. With the rapid pace of Research and Development (R&D) in medical devices, newer and more efficient surgical chips are being developed that enhance surgeons' capabilities. The Food and Drug Administration (FDA) has been increasingly approving innovative surgical devices, which has encouraged manufacturers to invest more in developing advanced surgical chips.
For example, the recent launch of smart chips with integrated functionalities is enhancing surgical precision and outcomes. These innovations not only provide better patient care but also drive the market growth of the US Surgical Chips Market Industry as hospitals and surgical centers seek to upgrade their equipment to offer the best technology to their patients.
The rise in the prevalence of chronic diseases among the US population is a significant driver for the US Surgical Chips Market Industry. According to the Centers for Disease Control and Prevention (CDC), approximately 6 in 10 adults in the United States have a chronic disease, with conditions such as diabetes, heart disease, and obesity leading to increased surgical interventions. This ever-growing patient population necessitates the need for effective surgical options, thereby increasing the demand for surgical chips that are essential for various surgical solutions.
The CDC projects that the prevalence of chronic diseases will continue to rise, which is expected to directly impact the surgical volume and consequently the demand for surgical chips within the US Surgical Chips Market Industry.
The US Surgical Chips Market, with its diverse Type segmentation, is poised for substantial growth as key technological advances continue to reshape the landscape of surgical procedures and diagnostics. Among the segmentation within this market, DNA chips have garnered significant attention due to their crucial role in genetic testing and personalized medicine, streamlining the identification of diseases at a molecular level.
Brain chips, on the other hand, are becoming increasingly essential in neurology and neurosurgery, allowing for better monitoring and treatment of neurological disorders, thus enhancing patient outcomes. Lab chips have revolutionized laboratory practices by minimizing reagent consumption and speeding up the testing processes, making them a preferred choice for many clinical and research environments.
Similarly, protein chips are critical in the evaluation and discovery of novel biomarkers for various diseases, aiding in the advancement of targeted therapies and improving diagnostic accuracy. Meanwhile, tissue chips have emerged as a vital component of regenerative medicine, offering innovative platforms for drug testing and disease modeling, effectively bridging the gap between laboratory research and clinical applications.
As the US continues to invest in Research and Development in medical technologies and genomic research, the relevance of each of these segments grows, leading to continuous innovation and enhanced patient care strategies across the healthcare system. The aforementioned segments reflect the growing emphasis on precision medicine and the need for rapid, reliable diagnostics, indicating a promising future for the US Surgical Chips Market.
The market's progress is being further fueled by advancing technologies, increasing healthcare expenditures, and a growing focus on personalized treatments, creating numerous opportunities for stakeholders and innovators within the industry. As these advancements unfold, the US Surgical Chips Market will likely witness a surge in adoption and application across various medical fields, reinforcing the importance of ongoing Research and Development initiatives.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The Application segment of the US Surgical Chips Market encompasses a diverse array of fields including Cancer Diagnosis and Treatment, Gene Expression, SNP Genotyping, Genomics, Clinical Diagnostics, and Others. Cancer Diagnosis and Treatment are critical areas as they drive significant advancements in precision medicine, leading to tailored therapeutic strategies and better patient outcomes.
Gene Expression analysis allows for detailed understanding of cellular mechanisms, contributing to insights in various health conditions. SNP Genotyping plays a vital role in personalized medicine, offering information about genetic predispositions and aiding in effective intervention strategies.
Genomics has transformed the landscape of healthcare by facilitating comprehensive genetic profiling and diagnostics, thereby enhancing disease management. Clinical Diagnostics contributes essential data for accurate disease detection, ensuring timely and appropriate care, while the 'Others' category captures emerging applications that reflect innovative trends within the market. The noteworthy growth in these areas aligns with increasing healthcare expenditure in the US and rising investments in Research and Development activities, indicating substantial potential for further advancements and market growth.
The End-Use Industry segment of the US Surgical Chips Market reflects a diverse range of applications, primarily encompassing Hospitals, Research Centers, and other entities. Hospitals are a significant component, as they serve as primary healthcare providers with high patient flow, necessitating advanced surgical technologies to enhance patient outcomes.
Meanwhile, Research Centers play a pivotal role in driving innovation and improving surgical techniques through Research and Development initiatives, thereby influencing the overall market growth. The importance of these centers is reflected in their contribution to developing new surgical chips that can be integral in various surgical procedures.
Other establishments, including outpatient surgical facilities and educational institutions, also contribute to market dynamics, although their impact may vary. Overall, the segmentation showcases a robust structure within the US Surgical Chips Market, indicating strong growth potential driven by advancements in technology and increasing demand for efficient surgical solutions across these industries.
The synergy between these segments highlights their collective importance in shaping future innovations in surgical applications.
The competitive landscape of the US Surgical Chips Market is characterized by various players striving to enhance their market positions through innovation and strategic initiatives. As the surgical industry continues to evolve, the need for advanced surgical chips has become paramount, leading to significant competition amongst manufacturers. Companies are focusing on developing cutting-edge technologies while adhering to regulatory standards to meet the demanding needs of healthcare professionals.
The competitive insights of this market reflect the ongoing trends towards improved efficiency, safety, and patient outcomes, highlighting the importance of research and development investments that drive differentiation. Key factors influencing competitiveness in this market include product quality, distribution networks, and customer engagement strategies, which all play crucial roles in capturing market share and fostering brand loyalty.
Smith and Nephew stands out in the US Surgical Chips Market through its commitment to innovation and quality in its surgical products. The company has leveraged its extensive research capabilities to develop advanced surgical chips which enhance surgical precision and improve procedural outcomes. Furthermore, Smith and Nephew has established a strong market presence thanks to its well-recognized brand and significant distribution network across the United States.
The company's strengths lie in its diverse portfolio of surgical solutions, which not only includes surgical chips but also other related surgical instruments, thus providing comprehensive coverage of surgical needs. This allows Smith and Nephew to maintain a competitive edge by offering integrated solutions tailored specifically for various surgical applications, thereby driving its demand in a rapidly evolving market environment.
Parker Hannifin has carved a significant niche in the US Surgical Chips Market by providing innovative solutions that span a range of applications in the surgical space. Known for its strong engineering expertise, Parker Hannifin focuses on developing high-performance surgical chips that enhance operational efficiency and enable improved patient care. The company has a robust presence in the United States, backed by strategically established partnerships and extensive distribution channels that facilitate broad market accessibility.
Parker Hannifin’s strengths are underscored by its commitment to innovation and quality, as demonstrated through continuous investment in research and development. Additionally, the company has engaged in strategic mergers and acquisitions aimed at diversifying its product offerings and enhancing its technological capabilities, thus positioning itself favorably within the competitive landscape of the US Surgical Chips Market while addressing the evolving demands of healthcare professionals.
The US Surgical Chips Market has seen significant developments recently, reflecting a robust growth trajectory. In October 2023, Medtronic announced the launch of a new line of advanced surgical chips designed for minimally invasive procedures, indicating increasing innovation and technology integration in the market. Additionally, in August 2023, Stryker reported substantial revenue growth attributed to the rising demand for surgical chips in orthopedic surgeries.
The merger activity in this space remains noteworthy; for instance, Smith and Nephew completed an acquisition of a smaller tech firm focused on surgical imaging in September 2023, aiming to enhance their portfolio in the surgical chip segment. Reports from Hologic in July 2023 highlighted increased investments in Research and Development, focusing on developing diagnostic capabilities linked to surgical chips, further emphasizing the competitive environment.
The growth in market valuation has been influenced by the rising adoption of robotics in surgical procedures, with companies like Intuitive Surgical leading with innovative solutions. Over the past two to three years, the market has witnessed remarkable shifts, including regulatory changes that have streamlined the approval processes for new surgical technologies, impacting the overall market dynamics significantly.
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2018 | 1.43(USD Billion) |
| MARKET SIZE 2024 | 1.55(USD Billion) |
| MARKET SIZE 2035 | 3.5(USD Billion) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 7.686% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Billion |
| KEY COMPANIES PROFILED | Smith and Nephew, Parker Hannifin, Hologic, Boston Scientific, Medtronic, Abbott Laboratories, Thermo Fisher Scientific, Stryker, B. Braun Melsungen, ConMed, AngioDynamics, Halyard Health, Johnson and Johnson, Intuitive Surgical |
| SEGMENTS COVERED | Type, Application, End-Use Industry |
| KEY MARKET OPPORTUNITIES | Minimally invasive procedures growth, Advanced surgical technology integration, Increasing demand for remote surgeries, Rising investment in healthcare technology, Expanding applications in diagnostics and therapeutics |
| KEY MARKET DYNAMICS | Technological advancements, Increasing surgical procedures, Rising geriatric population, High demand for minimally invasive surgeries, Growing adoption of smart medical devices |
| COUNTRIES COVERED | US |
Frequently Asked Questions (FAQ) :
The US Surgical Chips Market is expected to be valued at 1.55 billion USD in 2024.
By 2035, the US Surgical Chips Market is anticipated to reach a valuation of 3.5 billion USD.
The US Surgical Chips Market is expected to experience a CAGR of 7.686 percent from 2025 to 2035.
In 2024, Lab Chips are valued at 0.45 billion USD, making them the highest valued type of surgical chips.
By 2035, the market value of DNA chips is expected to reach 0.8 billion USD.
Key players in the market include Smith and Nephew, Medtronic, Boston Scientific, and Abbott Laboratories among others.
In 2024, the market size for Protein Chips is projected to be valued at 0.3 billion USD.
Emerging trends include advancements in biotechnology and increased adoption of personalized medicine.
The projected market size for Brain Chips by 2035 is 0.6 billion USD.
Challenges may include pricing pressures and the regulatory landscape affecting product approvals.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
